Tuesday, June 16, 2026

NewJeans Fights Back: K-Pop Group Seeks Justice Against Defamatory YouTube Account

The group NewJeans has drawn its sword...

Google Plans to Ditch Iconic Button for AI-Powered Search Feature

Google plans to replace its "I'm Feeling Lucky" button with an "AI Mode," enhancing its search experience amid growing AI competition.

Samsung Expands 2025 OLED TV Lineup with Award-Winning Innovations

Samsung's 2025 OLED TV lineup receives praise for its picture quality, glare-free technology, and advanced AI features, enhancing user experience.

Tag: pharmacokinetics

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

A Long-Acting Oral Drug? Yuhan’s Latest Trial Update Is Turning Heads

Yuhan Corp's YH35995 shows promising results for Gaucher disease in Phase 1 trial, demonstrating long-lasting efficacy and BBB penetration.

SJN314: The Promising New Immunotherapy for Chronic Inflammatory Diseases in Asia

Samjin Pharmaceutical submits phase 1 trial plan for SJN314, targeting immune diseases, aiming for global partnerships in early clinical phases.

Is RPG-102 the Future of Obesity Treatment? Discover the Breakthrough Oral Solution!

ProGen and Rani Therapeutics initiate a Phase 1 trial for RPG-102, an oral obesity treatment, aiming for effective weight loss with weekly dosing.

Celltrion’s ‘Psoriasis’ Biosimilar Poised to Challenge Big Pharma with Phase 1 Data

The EADV conference in Paris showcased Celltrion's biosimilar CT-P55, confirming its equivalence to Cosentyx in safety and pharmacokinetics.

Tumors Shrinking, Hopes Rising: Voronoi’s VRN11 Shows Over 40% Tumor Reduction in Early Lung Cancer Trial

Voronoi's VRN11 shows promising anti-cancer efficacy in early trials, reducing tumors in resistant lung cancer patients without major side effects.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.